ENA-INVESTMENT-CAPITAL
7.8.2020 13:02:10 CEST | Business Wire | Press release
ENA Investment Capital (“ENA”), a long-term, value-oriented investment firm and the second-largest shareholder in Ontex Group NV (“Ontex” or the “Company”) owning c.15% of the Company’s outstanding shares, today issued the following public letter to Ontex’s shareholders.
Dear Fellow Ontex Shareholders,
ENA Investment Capital, owning c.15% of the voting shares of Ontex, has devoted considerable time and resources to conduct a thorough analysis of Ontex. This includes acquiring a comprehensive understanding of the personal hygiene segment and, more importantly, of the Company’s turnaround potential which we are convinced, if effectively executed, can deliver significant value for shareholders.
As part of this extensive 18-month due diligence effort, we have consulted with former executives from Ontex as well as its main competitors, industry experts, investment bankers, lawyers and specialist consultants on a wide range of topics critical to Ontex’s business such as raw material trends and others. To assist us, we have partnered with two industry veterans who collectively have more than half a century of industry experience: Mr Gustavo Calvo Paz, the former President of Kimberly-Clark in Europe, and Mr Rodney Olsen, the former CFO of Kimberly-Clark International and Kimberly-Clark Asia-Pacific. We have also partnered with Mr Philippe Costeletos, the former head of Europe for private equity firm TPG, which owned Ontex between 2010-2014.
In the months since our public letter in February, we have had extensive private engagement with the Company including the exchange of seven letters with the Board, direct correspondence with the former and current Chairman, as well as discussions with reference shareholder GBL, other Board members and the Company’s appointed “defence” advisor Bank of America.
Following months of private engagement with the Company which culminated in the termination of former CEO Charles Bouaziz, we would like to share our perspectives on the current situation and the issues about which we are seeking specific assurances from the Board:
1. Ontex needs to immediately reset its strategy, review its global portfolio and broaden the scope of its restructuring plan
The termination of the CEO offers a unique opportunity for the interim management team – which had previously voiced internal dissent over the strategy devised by former CEO Charles Bouaziz – to undertake a comprehensive review of the Company’s strategic direction. It should do so unburdened by the past. Mr Bouaziz’s termination also allows the Board to be unhindered and to explore potential strategic alternatives or combinations (be they public or going private) that could maximise shareholder value.
We are concerned, however, that if management and the Board are not held to account then this could be yet another missed opportunity. The history does not read well.
The strategy pursued all these years with the acquisitions targeted has led to substantial value destruction. The 2019 restructuring plan (“T2G”) was a last-ditch attempt to stop the rot of a failed strategy, loss of market share and deteriorating margins. At its very announcement in May last year, however, Ontex’s share price collapsed 29% in just the 2 days following, and another ~20% from then until the CEO’s dismissal a few days ago. Shareholders clearly flagged their disapproval of this strategy from the moment of its public inception, and unfortunately their trepidation was proved right. Mr Bouaziz’s removal is a significant step forward that was long overdue and we hope not too late.
Ontex is left facing a series of complex tasks to revive its business and restore credibility. The next permanent Ontex CEO, be it an internal or external appointee, will need a unique mix of specific industry expertise, proven turnaround experience, and credibility with the capital markets. Viable candidates that meet these criteria are not easy to find, and we expect that a search for a new high-calibre CEO will take time. Time, however, is something Ontex does not have.
- The current management team, liberated from the influence of the prior CEO, should be brave in re-examining the Company’s failed strategy and un-ambitious T2G restructuring plan.
Management should aim to stabilise any loss of market share and restore cost competitiveness rather than reporting procurement gains that are, in reality, raw material tailwinds. We understand that interim CEO Thierry Navarre was one among several on Mr Bouaziz’s team who had pushed for a wider restructuring plan and had identified areas for additional improvement that were unfortunately ignored. We urge Mr Navarre and others to stand by these principles now that the influence of Mr Bouaziz has been removed.
Moreover, the CFO must move away from the non-standard and meaningless accounting measures introduced by the former CEO which masked deteriorating margins behind “alternative performance measures” such as “adjusted EBITDA” and “adjusted EBITDA at constant currency” despite the annual recurrence of what he called “non-recurring expenses”. To be clear, investors value the company on the basis of reported EBITDA.
2. Ontex is significantly undervalued - seeking meeting with the senior management team to discuss our value creation plan
We strongly believe that Ontex is valued significantly below its intrinsic value and has huge turnaround potential in terms of growth, margin improvement and cash flow conversion.
Based on the work we have done with our industrial partners (and various others) and validated by former executives of Ontex who were pushed out or resigned in disagreement with the failed strategy of the former CEO, we have developed our own well prepared views on Ontex’s ability to improve gross and EBITDA margins as well as cash flow conversion, under conservative low growth revenue assumptions.
- If Ontex pursued our plan, it should be able to deliver for shareholders ~300-400% returns from the current level over the mid-term based on our estimates.
Our targets are conservative, highly achievable, and entirely consistent with peers’ metrics. If the management team rejects them and/ or the Board cannot compel the management team to execute such a plan, it is due to either lack of ability, lack of ambition or – worse – both.
We think it is fair to have a thorough and sincere exchange of views with the current management team before we go public with such a plan. As such, we will be reaching out to the Company to meet with the new interim CEO as well as the CFO and other senior members of the management team to better understand their views on a broader restructuring plan as well as the targets we believe this business should be able to achieve.
3. Strategic alternatives need to be also considered, in parallel to a comprehensive CEO search and to developing a new stand-alone strategy
Notwithstanding the development of a credible standalone plan, the Board should form a “Strategy Committee” to work alongside the current management team (on a credible standalone strategy) and, in parallel, also explore various strategic alternatives.
The Board should not waste time. All strategic options should be on the table while searching for the right CEO in an accelerated timeframe. If they refuse to do so, the Chairman and GBL, the reference shareholder with representation on the Board, should provide a thorough explanation to shareholders as to why they think such a review is unnecessary.
Ontex is a company that was twice owned by private equity and still possesses attractive characteristics for private equity given its significant turnaround potential and market dominance in a high barrier to entry environment where retailer brands constantly win market share from branded competitors. The removal of Mr Bouaziz opens the door for such an approach. In addition, there are strategic M&A options available which have not been diligently explored so far, each of which could significantly rerate Ontex.
4. Seeking meeting with the Chairman as well as reference shareholder GBL
Given the gravity of the situation, we feel obliged to speak out at this critical time for the benefit of all shareholders.
So far, we have engaged with Ontex primarily in private out of respect for the Company as it managed through the Covid-19 peak. Despite our sincere efforts to work cooperatively and outside of the public domain, the Board frustrated our attempts at constructive dialogue by either dithering or forcing us to deal with a CEO for whom our objections were well known. We are hopeful that the Board’s decision to remove Mr Bouaziz signals a new openness and humility that will allow for meaningful dialogue about the future of our Company.
However, the share price performance prior to, and since, Mr Bouaziz was released from his role clearly shows that shareholders are losing what little confidence remains in the Company’s ability to remedy its vague strategic direction, poor execution, and a lack of strong Board oversight.
We will be meeting with the newly appointed Chairman Hans Van Bylen later this month and we will also seek to meet with a representative of GBL should they accept our invitation. We sincerely hope that Mr Van Bylen and GBL, respectively, approach these meetings with an open mind and without the excess of pride that blinded Mr Bouaziz to any constructive criticism and the facts. Both need to appreciate the seriousness of the situation and the urgent need to undertake our well-intentioned actions outlined above. Moreover, they need to be fully aware and honest about the magnitude of the tasks required by this Board to finally deliver value for all shareholders as well as reward the Ontex employees globally who have had to bear the cost of the restructuring.
Towards this goal, in these meetings, we will be asking for:
-
Assurances that…
The current Board of 8 members (some of whom having served since the 2014 IPO) has the capacity and appropriate industry and turnaround expertise to pursue simultaneously and in a short timeframe the following critical tasks:
- A comprehensive CEO search, including internal and external candidates, to ensure the best management team is in place to lead a turnaround of the Company;
- Provide hands-on support and oversee the current management team as it stabilises the business in Europe and reassure its employees;
- Actively help and guide the existing management team to reassess its current strategy and develop a new turnaround plan;
- Actively verify the US growth opportunity and assist with the execution, a key strategic objective for Ontex after the recent acquisition; and
- Establish a special “Strategy Committee” of qualified, industry knowledgeable individuals to work (a) alongside the current management team in reviewing strategy and turnaround plan; as well as (b) consider, explore and assess other strategic corporate alternatives for the Company (remaining public or going private, as a standalone company or combining with a competitor) to ensure the best outcome is decided for the Company, its employees and shareholders.
- Assurances that… The Board will run a comprehensive, objective, and transparent CEO recruitment process that takes into consideration input from shareholders, including those not presently represented on the Board.
- Assurances that… The Board will be open and supportive of the actions that management needs to take in order to review the current strategy and develop a value creation plan following our meeting, along the lines we describe above.
Both the Board and GBL must appreciate the urgent need for such assurances to be provided to shareholders.
We remain available to any fellow shareholders who wish to exchange thoughts, provide suggestions, or voice concerns so that we can share them with the Chairman, management and the reference shareholder GBL.
We are all in this together.
Sincerely,
ENA Investment Capital
View source version on businesswire.com: https://www.businesswire.com/news/home/20200807005128/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 16:37:00 CEST | Press release
Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory standardsFDA grants Compass NDA rolling submission and review request, based on Phase 3 dataCNPV awarded for COMP360, Compass’ proprietary formulation of synthetic psilocybin, for treatment-resistant depression (TRD)CNPV further accelerates momentum and Compass is confident and ready to deliver for patients Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be en
Banma Intelligence and Alipay Launch AI Cockpit Solution Powered by Alipay AI Pay, Enabling Seamless and Secure In-Car Transactions by Voice24.4.2026 16:04:00 CEST | Press release
At the 2026 Beijing International Automotive Exhibition (“Auto China 2026”), OS and AI technology company Banma Intelligence and Alipay today launched a new AI cockpit solution integrating Alipay AI Pay, enabling drivers to complete purchases by voice command directly from their vehicle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424618328/en/ Industry-first AI Cockpit Solution with Alipay AI Pay Unveiled “In the past two years, smart cockpits have achieved rapid advances in perception and decision-making,” said Ming Cai, Banma Intelligence Chief Product Officer. “With large models onboard, vehicles can understand user intent and make recommendations. By integrating Alipay AI Pay into our AI cockpit solution, we are removing the last friction point in the in-car smart cockpit experience - drivers simply speak to pay, no phone required.” The new AI cockpit solution initially covers two high-frequency use cases: enterta
Spatial Announces the Release 2026 1.0.1: New Enhancements Across 3D InterOp, Data Prep, Meshing, and 3D Modeling SDKs24.4.2026 15:21:00 CEST | Press release
Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced new enhancements across several of its product lines. These updates further strengthen Spatial’s commitment to delivering high-performance solutions that optimize interoperability, data preparation, and advanced modeling workflows. Designed to improve efficiency and robustness across CAD translation, modeling, meshing, and simulation processes, the latest updates introduce expanded format support, enhanced PMI handling, and new capabilities for complex geometry processing. 3D InterOp NX Reader Enhancement for 2D Drawings The NX reader imports 2D drawings as visualization data from NX 2412 and later versions. glTF Writer Supports Draco Compression glTF export incorporates Draco compression for meshes and point-clouds to significantly reduce output file sizes. Enhanced Support for Reading Product Manufacturing Information
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
